HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Rosenwald Selected Research

Biomarkers (Surrogate Marker)

6/2023Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium.
4/2022EMT, Stemness, and Drug Resistance in Biological Context: A 3D Tumor Tissue/In Silico Platform for Analysis of Combinatorial Treatment in NSCLC with Aggressive KRAS-Biomarker Signatures.
1/2022Reduced splenic uptake on 68Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis.
1/2021Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma.
1/2021The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
12/2019Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.
11/2018FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.
2/2018ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas.
5/2017New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies.
1/2017Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Rosenwald Research Topics

Disease

130Neoplasms (Cancer)
05/2024 - 04/2002
58Lymphoma (Lymphomas)
11/2023 - 12/2003
48Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023 - 06/2002
33Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2022 - 11/2005
32B-Cell Lymphoma (Lymphoma, B Cell)
02/2024 - 12/2002
22Multiple Myeloma
01/2023 - 01/2012
18Disease Progression
11/2023 - 09/2004
18Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2021 - 05/2002
15Hodgkin Disease (Hodgkin's Disease)
10/2023 - 11/2004
14Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2023 - 06/2003
14Burkitt Lymphoma (Burkitt's Lymphoma)
01/2023 - 06/2006
12Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021 - 04/2002
11T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 06/2009
8Neoplasm Metastasis (Metastasis)
02/2023 - 01/2012
8B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2016 - 06/2003
7Carcinogenesis
04/2022 - 04/2009
6Inflammation (Inflammations)
07/2023 - 10/2010
6Infections
12/2022 - 06/2003
6Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 08/2010
6Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021 - 01/2015
6Genetic Translocation (Chromosomal Translocation)
12/2016 - 12/2002
5Carcinoma (Carcinomatosis)
09/2023 - 08/2004
5Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2021 - 06/2009
5Adrenocortical Carcinoma
12/2018 - 11/2015
4Breast Neoplasms (Breast Cancer)
02/2023 - 03/2008
4Leukemia
05/2017 - 06/2004
3Adenoma (Adenomas)
01/2022 - 03/2012
3Melanoma (Melanoma, Malignant)
01/2019 - 08/2013
2Paraganglioma (Paragangliomas)
11/2023 - 01/2022
2Fibrosis (Cirrhosis)
07/2023 - 12/2008
2Squamous Cell Carcinoma of Head and Neck
01/2023 - 10/2016
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2023 - 07/2015
2Colitis
01/2023 - 07/2015

Drug/Important Bio-Agent (IBA)

41Proteins (Proteins, Gene)FDA Link
12/2022 - 04/2002
23Rituximab (Mabthera)FDA Link
02/2024 - 01/2011
21Biomarkers (Surrogate Marker)IBA
06/2023 - 07/2006
18DNA (Deoxyribonucleic Acid)IBA
01/2023 - 06/2002
16Vincristine (Oncovin)FDA LinkGeneric
02/2024 - 12/2011
15Doxorubicin (Adriamycin)FDA LinkGeneric
02/2024 - 12/2011
15Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2024 - 12/2011
15RNA (Ribonucleic Acid)IBA
12/2022 - 05/2005
14ParaffinIBA
11/2017 - 10/2008
13Prednisone (Sone)FDA LinkGeneric
02/2024 - 12/2011
12AntigensIBA
11/2023 - 05/2002
12MicroRNAs (MicroRNA)IBA
12/2022 - 09/2008
12Messenger RNA (mRNA)IBA
11/2021 - 02/2003
12Phosphotransferases (Kinase)IBA
01/2020 - 09/2005
11Cyclin D1IBA
01/2021 - 02/2003
11Formaldehyde (Formol)FDA Link
11/2017 - 10/2008
9AntibodiesIBA
01/2022 - 04/2009
8ibrutinibIBA
12/2022 - 09/2014
7CyclinsIBA
01/2021 - 12/2005
7Protein Isoforms (Isoforms)IBA
02/2017 - 06/2007
7Complementary DNA (cDNA)IBA
01/2013 - 07/2003
7NF-kappa B (NF-kB)IBA
05/2008 - 12/2002
6Chemokine ReceptorsIBA
12/2023 - 04/2015
668Ga-pentixaforIBA
12/2023 - 11/2017
6Etoposide (VP 16)FDA LinkGeneric
01/2023 - 11/2011
6CytokinesIBA
01/2023 - 02/2003
6Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
10/2021 - 06/2003
6Immunoglobulins (Immunoglobulin)IBA
01/2019 - 12/2002
6Immunoglobulin M (IgM)IBA
01/2019 - 04/2004
6Anaplastic Lymphoma KinaseIBA
05/2014 - 04/2002
5Keratins (Keratin)IBA
09/2023 - 01/2012
5Methotrexate (Mexate)FDA LinkGeneric
01/2023 - 10/2013
5carboxyl radical (COO-)IBA
09/2018 - 06/2011
4Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 11/2011
4Monoclonal AntibodiesIBA
01/2021 - 08/2013
4LigandsIBA
01/2021 - 11/2005
4Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 11/2011
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2019 - 11/2004
3Chimeric Antigen ReceptorsIBA
05/2024 - 01/2023
3bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2023 - 01/2021
3Prednisolone (Predate)FDA LinkGeneric
12/2022 - 09/2018
3Mitogen-Activated Protein KinasesIBA
05/2022 - 10/2010
3Lenalidomide (CC 5013)FDA Link
01/2021 - 09/2016
3AutoantigensIBA
01/2021 - 11/2015
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2020 - 07/2007
3Peptides (Polypeptides)IBA
01/2020 - 11/2013
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2019 - 03/2009
3ChemokinesIBA
10/2018 - 03/2009
3Glucose (Dextrose)FDA LinkGeneric
09/2016 - 08/2013
3Bortezomib (Velcade)FDA Link
09/2016 - 03/2009
3Endoplasmic Reticulum Chaperone BiPIBA
09/2016 - 01/2013
3Transcription Factors (Transcription Factor)IBA
09/2015 - 05/2005
3Cisplatin (Platino)FDA LinkGeneric
01/2014 - 03/2008
3Tyrosine (L-Tyrosine)FDA Link
01/2013 - 12/2010
3Cyclin D2IBA
11/2009 - 02/2004
3Indicators and Reagents (Reagents)IBA
01/2007 - 12/2005
2Bleomycin (Blenoxane)FDA LinkGeneric
07/2023 - 11/2019
2NucleotidesIBA
01/2023 - 01/2019

Therapy/Procedure

61Therapeutics
12/2023 - 02/2003
16Drug Therapy (Chemotherapy)
04/2021 - 06/2002
9Immunotherapy
05/2024 - 01/2013
9Stem Cell Transplantation
01/2023 - 11/2011
5Radiotherapy
10/2023 - 11/2019
4Aftercare (After-Treatment)
10/2021 - 05/2017
3Precision Medicine
11/2022 - 11/2017
3Cell Transplantation
01/2021 - 01/2013
3Salvage Therapy
01/2020 - 11/2011